Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2022-08-15 00:00:00 ET · period of report 2022-08-11 · accession 0001737287-22-000068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-15 | 2022-08-11+ | ALLO | WITTE OWEN N. | Dir | S - Sale | $16.75 | -15.0K | 223.3K | -6% | -$251.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-12 | S | D | 5,000 | $17.25 | 218,271 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-11 | S | D | 10,000 | $16.50 | 223,271 | D | — | — |